An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. MolinaCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAYuting SunCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAMarina ProtopopovaCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USASonal GeraCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAMadhavi BandiCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAChristopher A. BristowCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USATimothy McAfoosInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAPietro MorlacchiAgilent Technologies Inc., Lexington, MA, USAJeffrey J. AckroydDepartment of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USAAhmed-Noor A. AgipMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UKGheath AlatrashDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USAJohn M. AsaraBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAJennifer BardenhagenInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USACaroline C. CarrilloDepartment of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USAChristopher L. CarrollInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAEdward ChangCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAStefan O. CiureaDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USAJason B. CrossInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USABarbara CzakóInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAAngela K. DeemCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USANaval DaverDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAJohn Frederick De GrootDepartment of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USAJian-Wen DongDepartment of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USANingping FengCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAGuang GaoCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAJason GayCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAMary GeckInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAJennifer GreerInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAVirginia GiulianiCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAJing HanCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USALina HanDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAVerlene HenryDepartment of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USAJudy HirstMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UKSha HuangInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAYongying JiangInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAZhijun KangInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USATin Oo KhorCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USASergej KonoplevDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USAYu-Hsi LinDepartment of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USAGang LiuInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAAlessia LodiDepartment of Nutritional Sciences, University of Texas at Austin, Austin, TX, USATimothy LoftonInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAHelen MaDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAMikhila MahendraCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAPolina MatreDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USARobert A. MullinaxCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAMichael PeoplesCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAAlessia PetrocchiInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAJaime Rodriguez-CanaleDepartment of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USARiccardo SerreliMedical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UKThomas ShiCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAMelinda SmithCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAYoko TabeDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAJay TheroffInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAStefano TizianiDepartment of Nutritional Sciences, University of Texas at Austin, Austin, TX, USAQuanyun A. XuInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAQi ZhangDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAFlorian L. MüllerDepartment of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USARonald A. DePinhoDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USACarlo ToniattiCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAGiulio DraettaCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USATimothy P. HeffernanCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USAMarina KonoplevaDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAPhilip JonesInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAMaria Emilia Di FrancescoInstitute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USAJoseph R. MarszalekCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected]
2018en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0